Advanced ingestibles for probing the nexus between gastrointestinal functions and physical/mental well-being in animals and humans

The DeepDive project aims to develop innovative ingestible devices for accurately mapping gastrointestinal signals to enhance understanding of their impact on physical and mental health in humans and animals.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

Expanding on the “eHONESTY” ERC project about the link between body and moral decisions, the DeepDive PoC proposal aims to explore the neglected role of deep-body signals in modulating physical and mental health in humans and animals through the radically new approach of using ingestibles for mapping gastrointestinal (GI) physiology.

Market Gap

Crucially, although the market of ingestible devices is burgeoning, none of the existing products has the features needed for probing the link between GI dysfunctions and physical/mental well-being in humans and animals.

Project Objectives

To fill this outstanding gap, the DeepDive project aims to:

  1. Develop and test a class of ingestibles that can capture physiological signals from different tracts of the GI system (e.g., stomach, small/large intestine).
  2. Measure signals like endoluminal pH, pressure, and temperature with unprecedented accuracy and precision.
  3. Add causation to correlation by recording the GI neurons' activity before and after their electrical perturbation.

Ingestible Design

The inert capsules will be produced by:

  • Assembling specific components created using 3D printing.
  • Integrating a number of microscopic components ranging from solid-state pH, temperature, and pressure sensors to A/D–D/A Microconverter and RF Radio 2.4 GHz, in a sub-centimetric space.

Testing Methodology

GI functions at rest and in conditions of social stress will be tested in piglets using the new ingestible and in humans using commercial pills.

Regulatory Steps

All the steps towards patenting and obtaining permission for use in humans of the novel ingestible will be taken, and existing contacts with industrial partners and biomedical devices approval offices will be strengthened.

Expected Benefits

Given the link of gastroenterology with physical/mental dysfunctions and human/animal well-being, the project will have significant benefits at:

  • Neuroscientific levels
  • Medical levels
  • Societal levels

Economic Implications

Moreover, since the global market of ingestible sensors is expected to exceed $14 billion by 2026, DeepDive will likely have key economic implications.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZApenvoerder

Land(en)

Italy

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Minimally invasive endoscopes for neuronal activity monImaging-assisted single-cell specific activity monitoring and optogenetic stimulation of deep brain structures in motile and awaken animal models

WOKEGATE aims to enhance minimally invasive endoscopes for real-time monitoring of neuronal activity in awake animals, facilitating advanced neuroscience research and commercial applications.

€ 150.000
ERC Consolid...

Nanostructure formation during food protein digestion and influence on intestinal transport

PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.

€ 2.355.741
ERC Proof of...

PRoduction of an innOvative Millifluidic dEvice for TEsting of new prObiotics

The PROMETEO project aims to develop a millifluidic platform for studying probiotics in the gut microenvironment, enhancing drug development and clinical trial success rates.

€ 150.000
ERC Consolid...

Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition

The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.

€ 2.000.000
ERC Starting...

EARTHWORM: pEristAlsis in Real-Time Human mri to study the interWOven fRequency & Microstructural properties

EARTHWORM aims to revolutionize MRI techniques to study peristaltic motion and microstructure in the human body, enhancing diagnosis and modeling of related diseases.

€ 1.494.536

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH

iNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment.

€ 3.194.343
EIC Pathfinder

Enteric Bioelectronics for Sensing and Stimulating the CNS

EnterBio aims to develop bioelectronic tools for non-invasive modulation of the enteric nervous system to improve treatment of neurological disorders by leveraging gut-brain interactions.

€ 2.634.485
EIC Pathfinder

Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseases

The project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications.

€ 3.920.718
EIC Pathfinder

Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel Food

DiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions.

€ 3.999.222
EIC Pathfinder

Development of nutritional vesicles for precision diagnostics and therapeutics for metabolic diseases

The NutriEV project investigates food-derived extracellular vesicles as superfoods and biosensors to enhance gut health and metabolic regulation through innovative research and non-invasive biomonitoring.

€ 3.943.243